Obesity and C-reactive protein in various populations: A systematic review and meta-analysis

Obesity Reviews

Volumn 14, Issue 3, 2013, Pages 232-244

  Choi, J ^a   Joseph, L ^a,b   Pilote, L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

C reactive protein; Meta analysis; Obesity; Sex differences

Indexed keywords

C REACTIVE PROTEIN;

ADULTHOOD; AGE DISTRIBUTION; BODY MASS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ETHNICITY; HUMAN; META ANALYSIS (TOPIC); OBESITY; REVIEW; SEX DIFFERENCE; SEX RATIO; SYSTEMATIC REVIEW; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; SEX FACTORS; YOUNG ADULT;

EID: 84874021754     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12003     Document Type: Review

References (88)

1. Poirier P, Giles TD, Bray GA etal. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 2006; 113: 898-918.
2. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444: 875-880.
3. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-2138.
4. Pearson TA, Mensah GA, Alexander RW etal. Markers of inflammation and cardiovascular disease. Circulation 2003; 107: 499-511.
5. The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-140.
6. Brooks GC, Blaha MJ, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 2010; 106: 56-61.
7. von Elm E, Altman DG, Egger M etal. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
8. Lazarou C, Panagiotakos DB, Chrysohoou C etal. C-reactive protein levels are associated with adiposity and a high inflammatory foods index in mountainous Cypriot children. Clin Nutr 2010; 29: 779-783.
9. Wu DM, Chu NF, Shen MH etal. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children. J Clin Epidemiol 2003; 56: 94-100.
10. McDade TW, Rutherford JN, Adair L etal. Population differences in associations between C-reactive protein concentration and adiposity: comparison of young adults in the Philippines and the United States. Am J Clin Nutr 2009; 89: 1237-1245.
11. Vikram NK, Misra A, Dwivedi M etal. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 2003; 168: 305-313.
12. Nakamura H, Ito H, Egami Y etal. Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome. Diabetes Res Clin Pract 2008; 79: 330-336.
13. Panagiotakos DB, Pitsavos C, Yannakoulia M etal. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 2005; 183: 308-315.
14. Bastard JP, Maachi M, Lagathu C etal. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
15. Ferrante AW. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 2007; 262: 408-414.
16. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009; 6: 399-409.
17. Faucher G, Guénard F, Bouchard L etal. Genetic contribution to C-reactive protein levels in severe obesity. Mol Genet Metab 2012; 105: 494-501.
18. Khera A, Vega GL, Das SR etal. Sex differences in the relationship between C-reactive protein and body fat. J Clin Endocrinol Metab 2009; 94: 3251-3258.
19. Rossi I, Bochud M, Bovet P etal. Sex difference and the role of leptin in the association between high-sensitivity C-reactive protein and adiposity in two different populations. Eur J Epidemiol 2012; 27: 379-384.
20. Thorand B, Baumert J, Döring A etal. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006; 184: 216-224.
21. Abdullah SM, Khera A, Leonard D etal. Sex differences in the association between leptin and CRP: results from the Dallas Heart Study. Atherosclerosis 2007; 195: 404-410.
22. Bochud M, Marquant F, Marques-Vidal P-M etal. Association between C-Reactive protein and adiposity in women. J Clin Endocrinol Metab 2009; 94: 3969-3977.
23. Dullaart RPF, De Vries R, Dikkeschei LD etal. Higher plasma leptin largely explains increased C-reactive protein levels in women. Eur J Clin Invest 2007; 37: 231-233.
24. Viikari LA, Huupponen RK, Viikari JSA etal. Relationship between leptin and C-reactive protein in young finnish adults. J Clin Endocrinol Metab 2007; 92: 4753-4758.
25. Vettor R, De Pergola G, Pagano C etal. Gender differences in serum leptin in obese people: relationships with testosterone, body fat distribution and insulin sensitivity. Eur J Clin Invest 1997; 27: 1016-1024.
26. Lear SA, Chen MM, Birmingham CL etal. The relationship between simple anthropometric indices and C-reactive protein: ethnic and gender differences. Metabolism 2003; 52: 1542-1546.
27. Wee CC, Mukamal KJ, Huang A etal. Obesity and C-reactive protein levels among White, Black, and Hispanic US adults. Obesity (Silver Spring) 2008; 16: 875-880.
28. Khoo CM, Sairazi S, Taslim S etal. Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population. Diabetes Care 2011; 34: 1120-1126.
29. Liu S, Manson JE, Buring JE etal. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002; 75: 492-498.
30. Gaziano JM, Manson JE. Diet and heart disease. The role of fat, alcohol, and antioxidants. Cardiol Clin 1996; 14: 69-83.
31. Gunnell D, Frankel S, Nanchahal K etal. Childhood obesity and adult cardiovascular mortality: a 57-year follow-up study based on the Boyd Orr cohort. Am J Clin Nutr 1998; 67: 1111-1118.
32. Toprak D, Toprak A, Chen W etal. Adiposity in childhood is related to C-reactive protein and adiponectin in young adulthood: from the Bogalusa Heart Study. Obesity (Silver Spring) 2011; 19: 185-190.
33. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
34. Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Vasc Biol 1997; 17: 1822-1829.
35. Selvin E, Paynter NP, Erlinger TP. The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 2007; 167: 31-39.
36. Forsythe LK, Wallace JMW, Livingstone MBE. Obesity and inflammation: the effects of weight loss. Nutr Res Rev 2008; 21: 117-133.
37. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005; 45: 1563-1569.
38. Gentile M, Panico S, Rubba F etal. Obesity, overweight, and weight gain over adult life are main determinants of elevated hs-CRP in a cohort of Mediterranean women. Eur J Clin Nutr 2010; 64: 873-878.
39. Welsh P, Polisecki E, Robertson M etal. Unraveling the directional link between adiposity and inflammation: a bidirectional mendelian randomization approach. J Clin Endocrinol Metab 2010; 95: 93-99.
40. Timpson NJ, Nordestgaard BG, Harbord RM etal. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes 2011; 35: 300-308.
41. Frankenfield DC, Rowe WA, Cooney RN etal. Limits of body mass index to detect obesity and predict body composition. Nutrition 2001; 17: 26-30.
42. Freedman DM, Ron E, Ballard-Barbash R etal. Body mass index and all-cause mortality in a nationwide US cohort. Int J Obes 2006; 30: 822-829.
43. Gallagher D, Visser M, Sepúlveda D etal. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996; 143: 228-239.
44. Gomez-Ambrosi J, Silva C, Galofre JC etal. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes 2012; 36: 286-294.
45. Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond) 2008; 32(Suppl. 3): S56-S59.
46. Festa A, D'Agostino R Jr, Williams K etal. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes 2001; 25: 1407-1415.
47. Araujo F, Pereira AC, Latorre MDRDO etal. High-sensitivity C-reactive protein concentration in a healthy Brazilian population. Int J Cardiol 2004; 97: 433-438.
48. Arena R, Arrowood JA, Fei DY etal. The relationship between C-reactive protein and other cardiovascular risk factors in men and women. J Cardiopulm Rehabil 2006; 26: 323-329.
49. Aronson D, Bartha P, Zinder O etal. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes 2004; 28: 674-679.
50. Assoumou HGN, Barthelemy JC, Garet M etal. Increased waist circumference is the component of metabolic syndrome the most strongly associated with elevated C-Reactive protein in elderly. Metab Syndr Relat Disord 2011; 9: 281-285.
51. Choi EY, Park EH, Cheong YS etal. Association of C-reactive protein with the metabolic risk factors among young and middle-aged Koreans. Metabolism 2006; 55: 415-421.
52. Connelly PW, Hanley AJ, Harris SB etal. Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes 2003; 27: 347-354.
53. Doumatey AP, Lashley KS, Huang H etal. Relationships among obesity, inflammation, and insulin resistance in African-Americans and West Africans. Obesity (Silver Spring) 2010; 18: 598-603.
54. Dupuy AM, Jaussent I, Lacroux A etal. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome. Gerontology 2007; 53: 329-339.
55. Frohlich M, Imhof A, Berg G etal. Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care 2000; 23: 1835-1839.
56. Garcia-Lorda P, Bullo M, Balanza R etal. C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population. Int J Obes 2006; 30: 468-474.
57. Hak AE, Stehouwer CD, Bots ML etal. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999; 19: 1986-1991.
58. Hoekstra T, Geleijnse JM, Schouten EG etal. Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly. Nutr Metab Cardiovasc Dis 2005; 15: 270-278.
59. Hung J, Knuiman MW, Divitini ML etal. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. Am J Cardiol 2008; 101: 193-198.
60. Jeemon P, Prabhakaran D, Ramakrishnan L etal. Association of high sensitive C-reactive protein (hsCRP) with established cardiovascular risk factors in the Indian population. Nutr Metab 2011; 8: 19-27.
61. Kim K, Valentine RJ, Shin Y etal. Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults. Metabolism 2008; 57: 1181-1189.
62. Lee YJ, Lee JH, Shin YH etal. Gender difference and determinants of C-reactive protein level in korean adults. Clin Chem Lab Med 2009; 47: 863-869.
63. Lim S, Jang HC, Lee HK etal. The relationship between body fat and C-reactive protein in middle-aged Korean population. Atherosclerosis 2006; 184: 171-177.
64. Lin CC, Kardia SL, Li CI etal. The relationship of high sensitivity C-reactive protein to percent body fat mass, body mass index, waist-to-hip ratio, and waist circumference in a Taiwanese population. BMC Public Health 2010; 10: 579-587.
65. Marsland AL, McCaffery JM, Muldoon MF etal. Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism 2010; 59: 1801-1808.
66. McDade TW, Rutherford JN, Adair L etal. Adiposity and pathogen exposure predict C-reactive protein in filipino women. J Nutr 2008; 138: 2442-2447.
67. Mora S, Lee IM, Buring JE etal. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA 2006; 295: 1412-1419.
68. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men - the Minoh study. Circ J 2005; 69: 386-391.
69. Piche ME, Lemieux S, Weisnagel SJ etal. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol 2005; 96: 92-97.
70. Rogowski O, Shapira I, Bassat OKB etal. Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study. J Inflamm 2010; 7: 1-7.
71. Rohde LEP, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999; 84: 1018-1022.
72. Ryu SY, Lee YS, Park J etal. Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors. J Korean Med Sci 2005; 20: 379-383.
73. Saito I, Yonemasu K, Inami F. Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. Circ J 2003; 67: 323-329.
74. Saito I, Sato S, Nakamura M etal. A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study. Atherosclerosis 2007; 194: 238-244.
75. Snodgrass JJ, Leonard WR, Tarskaia LA etal. Anthropometric correlates of C-reactive protein among indigenous Siberians. J Physiol Anthropol 2007; 26: 241-246.
76. Thompson AM, Zhang Y, Tong W etal. Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China. Int J Cardiol 2011; 150: 247-252.
77. Visser M, Bouter LM, McQuillan GM etal. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
78. Yamada S, Gotoh T, Nakashima Y etal. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001; 153: 1183-1190.
79. Yudkin JS, Stehouwer CD, Emeis JJ etal. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
80. Al-Isa AN, Thalib L, Akanji AO. Circulating markers of inflammation and endothelial dysfunction in Arab adolescent subjects: reference ranges and associations with age, gender, body mass and insulin sensitivity. Atherosclerosis 2010; 208: 543-549.
81. Caserta CA, Pendino GM, Alicante S etal. Body mass index, cardiovascular risk factors, and carotid intima-media thickness in a pediatric population in Southern Italy. J Pediatr Gastroenterol Nutr 2010; 51: 216-220.
82. Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2003; 108: 1053-1058.
83. Kong APS, Choi K-C, Ko GTC etal. Associations of overweight with insulin resistance, beta-cell function and inflammatory markers in Chinese adolescents. Pediatr Diabetes 2008; 9: 488-495.
84. Lambert M, Delvin EE, Levy E etal. Prevalence of cardiometabolic risk factors by weight status in a population-based sample of Quebec children and adolescents. Can J Cardiol 2008; 24: 575-583.
85. Thomas NE, Baker JS, Graham MR etal. C-reactive protein in schoolchildren and its relation to adiposity, physical activity, aerobic fitness and habitual diet. Br J Sports Med 2008; 42: 357-360.
86. Visser M, Bouter LM, McQuillan GM etal. Low-grade systemic inflammation in overweight children. Pediatrics 2001; 107: E13-E19.
87. Warnberg J, Nova E, Moreno LA etal. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr 2006; 84: 505-512.
88. Yoshida T, Kaneshi T, Shimabukuro T etal. Serum C-reactive protein and its relation to cardiovascular risk factors and adipocytokines in Japanese children. J Clin Endocrinol Metab 2006; 91: 2133-2137.